Contemporary Management of Cardiovascular Disease in Women 2025

8th Annual Symposium | Gender-Specific Cardiology Updates & Clinical Strategies

📌 Overview

The 8th Annual Symposium on Contemporary Management of Cardiovascular Disease in Women 2025 is a comprehensive, evidence-based program focused on the unique aspects of cardiovascular disease in women.

This course explores sex-specific differences in diagnosis, treatment, and outcomes, addressing gaps in care and equipping clinicians with the knowledge needed to deliver more equitable and effective cardiovascular care.

📦 Course Specifications

• 🎥 Format: Video lectures only (no PDFs)
• 📅 Course Year: 2025
• 🧠 Level: Intermediate to Advanced

🎯 Target Audience

This course is ideal for:

• Cardiologists
• Internal medicine physicians
• Primary care physicians
• Nurse practitioners & physician assistants
• Nurses and pharmacists involved in cardiovascular care

🧠 What You Will Learn

❤️ Epidemiology & Risk in Women

• Unique cardiovascular risk factors in women
• Under-recognition and disparities in care
• Updated ASCVD risk assessment strategies

🫀 Cardiovascular Conditions in Women

• Coronary artery disease (CAD) in pregnancy
• Heart failure and hypertrophic cardiomyopathy
• Atrial fibrillation and cardiac amyloidosis

🩺 Valvular & Aortic Disease

• Sex differences in valve repair and replacement
• Aortic disease diagnosis and treatment
• Valvular heart disease in young women

💊 Pharmacologic & Preventive Therapies

• Lipid-lowering therapies (PCSK9 inhibitors, inclisiran, etc.)
• CKM syndrome treatments (finerenone, semaglutide)
• Hormone therapy considerations

⚙️ Advanced & Interventional Therapies

• Percutaneous valve repair techniques
• Renal denervation for resistant hypertension
• Baroreflex activation therapy for heart failure

📚 Course Topics Include

• Aortic disease in women
• Atrial fibrillation ablation
• Mitral and tricuspid valve repair differences
• Cardiovascular-kidney-metabolic (CKM) syndrome
• Acute coronary syndromes in pregnancy
• Cardiac amyloidosis
• Hypertrophic cardiomyopathy
• ASCVD prevention and risk assessment
• Chronic venous insufficiency
• Hypertension and renal denervation
• Lipid-lowering therapies updates
• Heart failure management in women

⚡ Key Benefits

• Understand gender-specific cardiovascular disease patterns
• Improve diagnosis and treatment in women
• Apply latest guidelines and therapies
• Reduce disparities in cardiovascular care
• Enhance clinical decision-making in complex cases

🚀 Why Choose This Course

• Focused exclusively on cardiovascular disease in women
• Covers modern pharmacologic and interventional therapies
• Case-based discussions for real-world application
• Ideal for clinicians seeking updated cardiology insights

💡 Clinical Value

This course is essential for healthcare providers who want to:

• Deliver personalized, gender-specific cardiovascular care
• Stay current with rapidly evolving cardiology treatments
• Improve outcomes for female patients with cardiovascular disease

l title in this course

Title	Runtime
Aortic Disease in Women: Diagnosis and Treatment	22:47
Atrial Fibrillation Ablation in Women	22:39
Sex Differences in Percutaneous Repair of Mitral and Tricuspid Valves	24:04
Finerenone and Semaglutide for the Treatment of Cardiovascular-Kidney-Metabolic (CKM) Syndrome	21:23
Acute Coronary Syndromes in Pregnancy	20:48
Therapeutic Options for Valvular Heart Disease in Young Women	19:32
Diagnosis and Treatment of Cardiac Amyloidosis in Women	24:09
Diagnosis and Management of Hypertrophic Cardiomyopathy in Women	22:28
Primary Prevention of ASCVD and Risk Assessment in Women	16:02
Management of Chronic Venous Insufficiency	15:04
Treatment of Hypertension: Role of Renal Denervation in Resistant Hypertension	18:01
New (and Traditional) Lipid Lowering Agents: Ezetimibe, PCSK9 Inhibitors, Inclisiran, Evanicumab, Bempedoic Acid	21:20
Baroreflex Activation Therapy (BAT) for Heart Failure with Reduced Ejection Fraction (HFrEF)	12:40
Updates in Medical Therapy for Heart Failure in Women	19:50
Cardiovascular Disease in Women: 2025 Update	27:41